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Many viruses, including human immunodeficiency virus type 1 (HIV-1), induce apoptosis and are affected by cellular
expression of antiapoptotic genes. We sought to examine the effect of antiapoptotic gene expression on HIV replication by
transfecting the promyelomonocytic cell line U937 with the bcl-xl gene to obtain clones of U937 cells that overexpressed
bcl-xl (designated U937bcl-xl), a negative control U937 clone transfected with vector alone (designated U937neo) and a clone
overexpressing bcl-2 (designated U937bcl-2). After infection with HIV-1, U937neo cells underwent apoptosis four times as
frequently as the U937bcl-xl cells. Furthermore, U937bcl-xl cells produced 5-fold less HIV-1 protein than U937neo, whereas
U937bcl-2 produced at least 2-fold more p24 than the U937neo control. Transient coexpression of bcl-2 or bcl-xl decreased
HIV production and transcription from the HIV LTR. To define the mechanism by which bcl-xl, but not bcl-2, inhibits HIV
expression, we examined bcl-2 and bcl-xl expression after HIV infection and CD4 cross-linking. Although HIV-1 infection or
cross-linking CD4 led to a decrease in expression of bcl-2, it had no effect on bcl-xl expression. These results provide a
mechanism for the resistance of U937bcl-xl transfectants, but not U937bcl-2 transfectants, to HIV-1 replication in monocytic
cells in vitro. Therapies that up-regulate bcl-xl expression potentially provide a novel means to decrease the destructiveness
of HIV-1. © 1999 Academic Press
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Apoptosis is a cell suicide program characterized by
NA digestion that allows for the elimination of danger-
us cells, such as cells that have accumulated genetic
amage or infectious virus (Thompson, 1995). Many vi-
uses possess genes that influence apoptotic pathways
Henderson et al., 1991, 1993; Lakshmi et al., 1992). The
cl-2 family of proteins acts to regulate apoptosis, and in
everal instances, overexpression of bcl-2 proteins ex-
rts a profound influence on the outcome of viral infec-
ions of the cell (Lin et al., 1995; Olsen et al., 1996; Scallan
t al., 1997; Thompson, 1995; Ubol et al., 1994). For
xample, influenza virus often induces apoptosis (Hin-
haw et al., 1994; Takizawa et al., 1993), and inhibition of
poptosis by bcl-2 decreases virus yield (Olsen et al.,
996; Scallan et al., 1997).
The relationship between bcl-2 proteins and HIV in-
ection has been addressed in a handful of studies. The
IV tat induces bcl-2 and blocks apoptosis (Zauli et al.,
995), or alternatively, tat increases apoptosis (Li et al.,
995; Westendorp et al., 1995). HIV infection in B cells
DeRossi et al., 1994) and T cells (Strack et al., 1996) is
ssociated with a loss of bcl-2, followed by apoptosis
DeRossi et al., 1994; Strack et al., 1996). In this recent
tudy (Strack et al., 1996), there was a decrease in HIV
1 To whom reprint requests should be addressed. Fax: 617-632-4257.
u-mail: bill_marshall@macmailgw.dfci.harvard.edu.
1eplication in T cells overexpressing bcl-2 in the first few
ays after infection. In two other studies, overexpression
n T cells of either bcl-2 (Antoni et al., 1995; Sandstrom et
l., 1996) or the adenoviral bcl-2 homolog E1B (Antoni et
l., 1995) resulted in decreased early p24 production, a
lock to HIV-induced apoptosis, the appearance of syn-
ytia, and increased HIV replication at later time points in
nfection (Antoni et al., 1995; Sandstrom et al., 1996).
Although syncytial spreading of HIV infection is hy-
othesized to explain these in vitro results (Sandstrom et
l., 1996), the pathogenic significance of syncytia is un-
lear in vivo (Rosenberg and Fauci, 1989). Furthermore,
he phenomenon of decreased bcl-2 expression after
IV infection (DeRossi et al., 1994; Strack et al., 1996)
ay confound analyses focusing solely on bcl-2 (Sand-
trom et al., 1996) or cells overexpressing bcl-2 and E1B
Antoni et al., 1995). To address the former concern, we
sed HIV-infected U937 cells, which are naturally less
usceptible to syncytium formation (Asjo et al., 1987). To
ddress the latter concern, we used the bcl-xl gene
Boise et al., 1993), which had not been previously ex-
mined in regard to its effect on HIV infection.
RESULTS
To compare the levels of bcl-2 with those of bcl-xl in a
ell line that naturally expresses bcl-2 and bcl-xl (Fig. 1
nd Table 1), we chose H9 T cells, which express both
cl-2 and bcl-xl. After HIV infection, bcl-xl expression is
nchanged (Fig. 1A), whereas bcl-2 expression de-
0042-6822/99 $30.00
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2 MARSHALL ET AL.reases dramatically, compared with uninfected control
ells, at day 5 postinfection (Fig. 1B), when 27% of cells
ere undergoing apoptosis (data not shown). Further-
ore, as a quantitative analysis, an intracellular stain for
cl-2 expression was performed with a polyclonal anti-
ody that recognizes bcl-2. This staining revealed loss of
5% of bcl-2 (Table 1). After HIV infection, virtually no loss
f bcl-xl is detected using a polyclonal antibody directed
gainst bcl-x. Using the monoclonal antibody, 7B2, which
as generated using portions of bcl-xl as the immuno-
en (Datta et al., 1995), similar results were obtained
data not shown). Thus although bcl-2 expression de-
reases after HIV infection, bcl-xl expression does not.
FIG. 1. Immunoprecipitation followed by immunoblot analysis of
IV-infected H9 cells demonstrates loss of bcl-2 expression, not bcl-xl
xpression. Equal numbers of H9-infected and H9-noninfected cells
ere lysed, analyzed, and probed with anti-bcl antibodies as described
n the text. (A) Immunoblot of bcl-xl demonstrates a band of 29 kDa (see
rrow) in the left lane containing lysate from HIV (2) and (1) H9 cells,
espectively. This band is also present in the U937bcl-xl lysate, but it is
aint in the lane containing lysates from U937neo. (B) Immunoblot of
cl-2 demonstrates a band of appropriate size in the two neighboring
anes that contains lysates from HIV (2) and (1) H9 cells, respectively.
he band at 26 kDa (see arrow) appears less intense in the HIV (1)
ane. (C) Flow cytometric analysis of U937 cells demonstrates in-
reased bcl-xl expression on U937bcl-xl transfectants. Fixed, perme-
bilized cells were incubated with 7B2 anti-bcl-xl or control IgG3
onoclonal antibodies, washed, incubated with goat anti-mouse FITC,
nd analyzed by flow cytometry. Leftmost curves indicate IgG3, nega-
ive control fluorescence. The greatest level of expression is ini937bcl-xl (right).To assess the effect of expression of bcl-xl on HIV
eplication and apoptosis, we chose U937 cells, which
aturally express low basal levels of bcl-xl. The level of
xpression of bcl-xl in U937neo and U937bcl-xl cells is
emonstrated by immunoblotting (Fig. 1A) and flow cy-
ometric analysis (Fig. 1C). There is a low level of ex-
ression of bcl-xl in the control U937neo cells (Fig. 1C,
eft ) compared with the U937bcl-xl transfectants, which
verexpress the bcl-xl protein (Fig. 1C, right ).
Other studies had demonstrated that bcl-2 overexpres-
ion decreases HIV-induced apoptosis (Antoni et al.,
995; Sandstrom et al., 1996; Strack et al., 1996), and our
ata (not shown) indicate a decrease in apoptosis from
5% in U937neo to 3% in U937bcl-2. Having character-
zed bcl-xl in U937 transfectants, we next addressed the
ffect of bcl-xl expression on the response of U937 cells
o HIV infection. Figure 2 demonstrates that bcl-xl ex-
ression inhibits apoptosis induced by HIV-1MN. H9 T
ells readily undergo apoptosis, as do U937neo cells,
lbeit at a later date. Apoptosis is demonstrated by the
ppearance of a peak in the subdiploid region that is
epresentative of the apoptotic population (Nicoletti et
l., 1991). Thus at day 4 postinfection, 38.5% of H9 cells
ere undergoing apoptosis compared with only 3.5% of
ninfected controls (Fig. 2). The U937bcl-xl cells do not
ndergo apoptosis (7% at day 17) to the same extent as
937neo (30% at day 17) and produce 5-fold less HIV
han U937neo (Fig. 3).
It is notable that the initial production of p24 shown
n Fig. 3 is comparable between the U937neo and
937bcl-xl through day 14, diverging only after the
ppearance of significantly more apoptosis in the
937neo population. This initial similarity in HIV infec-
ion kinetics suggests that initial steps in replication
uch as entry were not altered between U937neo and
937bclxl. In keeping with this, the surface expression
f CD4 was comparable between cell lines (data not
hown). By day 28, the p24 values for the U937neo
ersus U937bcl-xl were 500 versus 100 pg/ml, respec-
ively. To further address the possibility that the effect
f bcl-xl could be due to clonal differences between
he U937 transfectants, we tested four other separate
lones of U937bcl-xl; all were equally resistant to HIV
nfection compared with the U937 parent and U937neo
Table 2). These results are consistent with the con-
lusion that bcl-xl overexpression is associated with
ecreased p24 production.
To address the mechanistic questions raised by these
bservations, we tested the hypothesis that the de-
rease in p24 seen with bcl-xl overexpression was due
o a decrease in HIV transcription. To this end, HeLa
ells cotransfected with HIV proviral DNA and pSFFVbcl-
l, pSFFVneo, or pSFFVbcl-2 encoding bcl-xl, neomycin
hosphotransferase (a control), or bcl-2, respectively,
ere analyzed for p24 production. The results depictedn Fig. 4 demonstrate that both bcl-2 and bcl-xl expres-
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3bcl-xl INHIBITS HIV-1 AND APOPTOSISions decrease HIV production acutely. In Fig. 4A, HIV
24 was measured to determine the effect of bcl-2 or
cl-xl proteins on HIV production in a single cycle infec-
ion. The bcl-2 and bcl-xl transfectants both produced
ess HIV p24 than control transfectants. To further refine
he mechanism for this effect, in Fig. 4B HIV long terminal
epeat (LTR) b-galactosidase activity (Klimpton and
merman, 1992) was measured to determine the effect of
cl-2 or bcl-xl proteins on transcription from the HIV LTR
Fig. 4B). Transient transfection with both bcl-2 and bcl-xl
ransfectants resulted in less HIV LTR-driven b-galacto-
idase activity. Thus both bcl-2 and bcl-xl vectors sup-
ressed transcription from the HIV LTR. Because bcl-xl
xpression was unaffected by HIV infection (Fig. 1 and
able 1), we hypothesized that the difference in HIV
roduction might relate to the fact that bcl-2 decreased
fter HIV-1 infection, whereas bcl-xl expression did not.
T
Flow Cytometric Analysis of Intracellular bc
Whereas bcl-2 Expression De
bcl-xl
Control Anti-bcl-x
Difference in mean
fluorescence
92 41.25 204.52 163.27
91 58.53 218.20 159.67
Note. H9 T cells were infected and then stained for bcl expression a
hown). This staining revealed loss of 35% of bcl-2, whereas virtually
FIG. 2. The bcl-xl inhibits apoptosis induced by HIV. H9, U937, and U9
escribed previously (Marshall et al., 1992). Cells were pelleted and rehe text and analyzed by flow cytometry for apoptosis. The percent of cells ghat mechanism explains the difference between the
ffects of HIV infection on bcl-2 versus bcl-xl?
Cross-linking of CD4, which is a consequence of HIV-1
nfection, has been demonstrated to down-regulate bcl-2
Hashimoto et al., 1997). Because HIV-1 infection did not
ead to decreased bcl-xl expression, we hypothesized
hat bcl-xl expression might be unaffected by CD4 cross-
inking. To test this hypothesis, we induced cross-linking
f surface CD4 by incubating cells with anti-CD4 or
nti-Thy 1.2 (a control), followed by donkey anti-mouse
ntiserum. Cross-linking of CD4 resulted in a 33% de-
rease versus control cells in median fluorescence for
cl-2 but not for bcl-xl. This indicates that bcl-2 is regu-
ated by CD4 cross-linking, whereas bcl-xl is not. This
ifference in regulation of bcl-2 family members by CD4
ross-linking may explain the difference in expression of
cl-2 versus bcl-xl after HIV infection (Fig. 1 and Table 1).
ression Reveals Virtually No Loss of bcl-x,
s by 35% after HIV Infection
bcl-2
Control Anti-bcl-2
Difference in mean
fluorescence
H92 33.60 182.39 148.79
H91 18.74 115.52 96.78
postinfection when 27% of cells were undergoing apoptosis (data not
of bcl-xl was detected.
xl cells were infected at a multiplicity of infection of 5.0 using methods
nded in hypotonic buffer containing propidium iodide as described inABLE 1
l-xl Exp
crease
t day 537bcl-
suspeated in the subdiploid peak is displayed over the region gated M1.
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4 MARSHALL ET AL.DISCUSSION
Our experiments show that the expression of bcl-xl
ecreases HIV-induced apoptosis and HIV replication in
937 monocytic cells. In accord with the data of Fig. 4
emonstrating an inhibitory effect of bcl-2 family mem-
ers on HIV production and transcription, increased
cl-xl expression is correlated with decreased p24. The
cl-2 does not decrease p24 (Fig. 3). In keeping with our
bservation with bcl-2, E1B, a bcl-2 homolog, prolongs
IV replication in T cells (Antoni et al., 1995), and bcl-2
as been shown to prolong the life span of syncytial T
ells and to enhance cell-to-cell spread of HIV (Sand-
trom et al., 1996). In another study, overexpression of
cl-2 suppressed HIV replication early in HIV infection
hen bcl-2 levels remain high, which appears to be a
ontradictory result (Strack et al., 1996).
One reason for the discrepancy among studies of effects
f bcl-2 family members on HIV replication (Antoni et al.,
995; Sandstrom et al., 1996; Strack et al., 1996) relates to
he fact that bcl-2 can be downmodulated by CD4 cross-
inking (see Results and Hashimoto et al., 1997). Overex-
ression of bcl-xl (Fig. 1), the decreased sensitivity of bcl-xl
FIG. 3. The bcl-xl expressors produce less HIV p24 antigen after HIV
nfection. U937neo and U937bcl-xl cells were infected and superna-
ants were harvested at the times indicated for analysis by p24 ELISA
DuPont). Lysates were from identical cell concentrations or corrected
ppropriately. Values were comparable until day 14 postinfection, when
24 values for U937neo versus U937bcl-xl diverged to 2- to 10-fold less
24 for U937bcl-xl. Results were consistent with four independent
xperiments.
TABLE 2
HIV Replication in Monocytic Cells Can Be Inhibited by bcl-xl
Expression in Several Different Clones
Mean p24
(pg/ml) SD
U937 parent 8338 4060
U937neo 5911 232
bcl-xl transfectants
Clone 1 2718 495
Clone 2 2035 1
Clone 3 2116 621
Clone 4 2519 4bNote: SD represent standard deviationo CD4 cross-linking, and its stable expression in HIV-
nfected cells (Fig. 1) may contribute to the relative apopto-
is resistance of U937bcl-xl compared with U937neo cells
Fig. 2). What distinguishes our finding from those with bcl-2
Sandstrom et al., 1996) and E1B (Antoni et al., 1995) is that
cl-xl expression is not decreased in HIV infection (Fig. 1
nd Table 1) and does not enhance HIV replication (Fig. 3).
hese results reexamine the concept (Thompson, 1995)
hat bcl-2 family members can strongly influence viral rep-
ication and demonstrate that bcl-2 and bcl-xl can have
ifferent effects.
The means by which bcl-2 family members effect de-
reased viral production are complex. Previously pro-
osed mechanisms for the effect of bcl-2 family mem-
FIG. 4. Transient transfection of bcl-2 and bcl-xl vectors suppressed
IV replication as well as transcription from the HIV LTR. (A) HIV p24
as measured to determine the effect of bcl-2 or bcl-xl proteins on HIV
roduction in a single cycle infection. (B) HIV LTR b-galactosidase
ctivity was measured to determine the effect of bcl-2 or bcl-xl proteins
n transcription from the HIV LTR. Compared with pSFFVneo vector,
SFFVbcl-2 and pSFFVbcl-xl vectors significantly (P 5 0.01) sup-
ressed transcription from the HIV LTR.ers on viral replication are altered: NF-kB activity (Lin et
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5bcl-xl INHIBITS HIV-1 AND APOPTOSISl., 1995; Strack et al., 1996), viral glycosylation (Olsen et
l., 1996), or viral release (Scallan et al., 1997). Recent
tudies have demonstrated that HIV protease digests
cl-2 and have indicated that this triggers increases in
ntracellular NF-kB (Strack et al., 1996), which may then
rive HIV replication. Our preliminary data are in accord
ith other results demonstrating the ability of bcl-2 or
cl-xl to suppress NF-kB-mediated transcription (Grimm
t al., 1996). The modest, statistically significant, tran-
criptional attenuation of the HIV LTR by bcl-xl and bcl-2
oexpression with HIV (Fig. 4) is consistent with the
ffects of bcl-2 overexpression in the first days postin-
ection in T cells in two studies (Antoni et al., 1995; Strack
t al., 1996). Later, after bcl-2 is cleaved (Strack et al.,
996) or downmodulated (Fig. 1) in HIV-infected cells, our
esults (Fig. 3) and those of others (Antoni et al., 1995;
andstrom et al., 1996; Strack et al., 1996) suggest that
cl-2 overexpression does not protect against HIV repli-
ation and that it may even enhance its spread. The
cl-xl expression protects against HIV-induced apopto-
is (Fig. 2) and HIV transcription (Fig. 4) to a greater
xtent than bcl-2, perhaps because it is not susceptible
o downmodulation by CD4 cross-linking resulting in
ecreased HIV replication (Fig. 3).
Opportunistic viral regulation of the cell death appa-
atus may have a profound effect on RNA or DNA virus
roduction. The RNA virus Sindbis virus is avirulent in
cl-2 overexpressing cells; mutants of Sindbis virus be-
ome virulent when they are able to induce apoptosis
espite bcl-2 expression (Ubol et al., 1994). Similarly, the
lycosylation and infectious titers of influenza virus are
ecreased in cells overexpressing bcl-2 (Olsen et al.,
996). Thus opportunistic viral regulation of the cell death
athway can have profound effects on viral production.
ur experiments show that in U937 monocytic cells, the
xpression of bcl-xl decreases HIV-induced apoptosis
nd HIV replication.
These results are the first to suggest that bcl-xl overex-
ression functions to prevent infectious viral spread in a
ay analogous to bcl-2 in other viral infections (Olsen et al.,
996; Scallan et al., 1997; Strack et al., 1996; Ubol et al.,
994). Our results are consistent with the previous finding
hat CD28 signalling, which induces bcl-xl expression in T
ells (Boise et al., 1995), also inhibits HIV-induced apopto-
is (Groux et al., 1992). Furthermore, it may be possible to
se cytokines that up-regulate bcl-xl or bcl-xl gene overex-
ression to inhibit HIV-induced apoptosis and production in
ivo. Finally, combined with potent antiretroviral therapy,
nhibition of apoptotic cell death may hasten the return of
epleted immune cells.
MATERIALS AND METHODS
ell culture and infections
U-937 transfectants were prepared as described pre-
iously (Datta et al., 1995). Transfectants were main- bained in the presence of 400 mg/ml geneticin sulfate
ntil day 0 of infection. H9 cells and U937 clones were
nfected with HIV-1MN (obtained from the AIDS Reposi-
ory) at a multiplicity of infection of 5.0 or 25.0, depending
n the experiment, as described previously (Marshall et
l., 1992). Virus was passaged in H9 cells fed twice
eekly and carried in RPMI 1640, 10% bovine calf serum,
00 mg/ml L-glutamine, penicillin–streptomycin (GIBCO
RL), and 20 mg/ml ciprofloxacin. Infectious superna-
ants were obtained by centrifuging cells at 2000g fol-
owed by filtration through a 0.45-mm filter. Supernatants
ere stored at 270°C before use.
ransient transfection of bcl-2/x vectors into HIV LTR
-galactosidase vector-containing HeLa cells
HeLa cells containing the HIV LTR promoter driving a
-galactosidase construct (Klimpton and Emerman,
992) were used to measure the effect of bcl-2 or bcl-xl
roteins on transcription from the HIV LTR. Cells were
lectroporated with 2.5 mg of pEGFP and 5 mg of
SFFVbcl-xl, pSFFVneo, or pSFFVbcl-2. Lysates obtained
t day 3 posttransfection were incubated with buffer and
PRG substrate. Values for b-galactosidase activity (a
easure of transcriptional activity from the LTR con-
truct) were obtained by measurement of absorbance at
70 nm. Statistical analysis of the data from octuplicate
amples of the bcl-2 and neo transfectants was per-
ormed using the unpaired t test. In other experiments,
eLa cells cotransfected with HIV proviral DNA (DFCI-
T, a gift of Erik Langhoff) were used to measure the
ffect of bcl-2 or bcl-xl proteins on p24 production. Cells
ere electroporated with 2.5 mg of HIV vector and 5 mg
f pSFFVbcl-xl, pSFFVneo, or pSFFVbcl-2. Lysates ob-
ained at day 2 posttransfection were tested for p24.
ector construction and plasmids
Cloning and construction of plasmids pSFFVbcl-xl,
SFFVneo, or pSFFVbcl-2 were described previously
Boise et al., 1993); these plasmids were provided by Dr.
akesh Datta.
mmunoprecipitation and Western blotting
Cells (107/sample) at day 4 postinfection with HIV-1MN
ere washed in PBS and lysed on ice for 1 h in 100 ml of
lysis buffer composed of 0.5% Nonidet P-40, 300 mM
aCl, 50 mM Tris, pH 7.6, 0.15 U/ml aprotinin, 5 mM
DTA, and 1 mM PMSF. After centrifugation for 20 min at
4,000 rpm at 4°C, lysates were precleared with 100 ml of
0% (w/v) donkey anti-mouse heteroserum (Jackson Im-
unologicals)-coated protein A–Sepharose beads (Phar-
acia) for 30 min at 4°C. Lysates were then precipitated
n mouse anti-bcl-xl (7B2; Datta et al., 1995) or bcl-2
MBL, Nagoya)-coated protein A–Sepharose beads for
h at 4°C. Samples were washed twice, eluted from
eads via boiling in Laemmli’s buffer for 5 min, and
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6 MARSHALL ET AL.lectrophoresed on a 12% SDS–polyacrylamide gel.
ransfer to 0.45-mm nitrocellulose was followed by
locking in 5% donkey serum/3% powdered milk/PBS
nd 0.5% Tween 20. The nitrocellulose was probed with
nti-bcl-xl or bcl-2 rabbit polyclonal antibodies (Santa
ruz Biotechnology) for 1 h and later probed with a
onkey anti-rabbit peroxidase (Jackson Immunologicals)
or 1 h. Between the blocking and each antibody step, the
itrocellulose was washed repeatedly with PBS and 0.5%
ween 20. The immunoblot was visualized by the ECL
eveloper system (Amersham, Arlington Heights, IL).
24 assays
P24 concentration was determined by ELISA accord-
ng to the manufacturer’s specifications (DuPont–NEN,
oston, MA).
mmunofluorescence assays
The expression of intracellular antigens was assessed
y immunofluorescence flow cytometry with a FACscan
low cytometer (Becton-Dickinson). Cells were fixed in
% paraformaldehyde/PBS and labeled in suspension
ith saturating amounts of anti-bcl-xl (no. 65186; Phar-
ingen) and an polyclonal antibody, Bcl-2 N-19 (no. SC-
92; Santa Cruz Biotech), specific for bcl-2 N-terminus,
sing methods described previously (Dattaet al., 1995).
s a control, another aliquot of cells was also incubated
eparately with an irrelevant heterosera (Sigma). Label-
ng with primary antibodies was followed by incubation
ith fluorescein isothiocyanate-conjugated goat anti-
abbit polyvalent immunoglobulin (Sigma).
D4 cross-linking
Methods were as modified from the study of Hashi-
oto et al. (1997). Briefly, Falcon 2054 tubes were coated
ith donkey anti-mouse antibody (Jackson Immunologi-
als) 100 ml of 100 mg/ml 30 mM NaHCO3 and 30 mM
a2CO3, pH 9.6, by incubation for 1 h at 37°C and
ashing five times in PBS. Cells were treated for 40 min
ith either no antibody, anti-CD4 (Leu 3A; Becton-Dick-
nson), or anti-Thy 1.2 at 10 mg of antibody/2 3 106 cells
t 4°C. Cells were incubated for 3 days and analyzed for
cl-2 expression as described previously (Hashimoto et
l., 1997) using the flow cytometric techniques outlined
bove.
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